Outcomes of Surgical Intervention Following Preventive Mastectomy in BRCA1 and BRCA2 Mutation Carriers - Top-Institutions - MDSpire

Outcomes of Surgical Intervention Following Preventive Mastectomy in BRCA1 and BRCA2 Mutation Carriers

  • By

  • Rebecca Wiberg

  • Signe Hägglund

  • Barbro Numan Hellquist

  • Anna Rosén

  • Annika Idahl

  • Maria Mani

  • Svetlana Bajalica-Lagercrantz

  • Hans Ehrencrona

  • Per Karlsson

  • Niklas Loman

  • Malin Sund

  • Swedish BRCA Study Group

  • Åke Borg

  • Anna Öfverholm

  • Anna von Wachenfeldt

  • Christina Edwinsdotter Ardnor

  • Ekaterina Kuchinskaya

  • Johanna Rantala

  • Ylva Karlsson

  • April 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Surgical Oncology
    • Genetic Counseling
    • Reconstructive Surgery

  • #2

    Dana-Farber/Brigham and Women's Cancer Center
    Dana-Farber/Brigham and Women's Cancer Center

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Genetics
    • Plastic Surgery

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Surgical Oncology
    • Genetic Risk Assessment
    • Reconstructive Surgery

  • #4

    The Royal Marsden NHS Foundation Trust
    The Royal Marsden NHS Foundation Trust

    London, England

    Key Differentiators

    • Breast Oncology
    • Genetic Counseling
    • Surgical Oncology

  • #5

    Karolinska University Hospital
    Karolinska University Hospital

    Stockholm, Sweden

    Key Differentiators

    • Breast Surgery
    • Genetic Oncology
    • Reconstructive Surgery

Original Source(s)

Outcomes of Surgical Intervention Following Preventive Mastectomy in BRCA1 and BRCA2 Mutation Carriers

  • by Rebecca Wiberg, Signe Hägglund, Barbro Numan Hellquist, Anna Rosén, Annika Idahl, Maria Mani, Svetlana Bajalica-Lagercrantz, Hans Ehrencrona, Per Karlsson, Niklas Loman, Malin Sund, Swedish BRCA Study Group, Åke Borg, Anna Öfverholm, Anna von Wachenfeldt, Christina Edwinsdotter Ardnor, Ekaterina Kuchinskaya, Johanna Rantala, Ylva Karlsson

  • April 3, 2026

Related Content

Efficacy and safety of hypofractionated versus conventional radiotherapy in breast cancer: a systematic review and meta-analysis

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

  • by

  • May 25, 2026

  • 9 min
Editorial: Epigenetic modulation in cancer